Meeting Report

CAR T-Cell Therapy and the Pharmacology of Managing Cytokine Release Syndrome

Presented by Jae Park, MD, and Amber C. King, PharmD, BCOP

Memorial Sloan Kettering Cancer Center, New York, New York

Presenters’ disclosures of conflicts of interest are found at the end of this article.


J Adv Pract Oncol 2019;10(3):212–215 | https://doi.org/10.6004/jadpro.2019.10.3.2 | © 2019 Harborside™


  

ABSTRACT

Jae Park, MD, and Amber C. King, PharmD, BCOP, shared background and clinical information regarding CAR T-cell therapy in acute lymphoblastic leukemia and large-cell lymphoma, as well as strategies to mitigate cytokine release syndrome and other serious side effects of therapy.




For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.